Risco de desenvolver câncer em receptores de sangue violetado: validade da entrevista

CARTA AO EDITOR

Risco de desenvolver câncer em receptores de sangue violetado. Validade da entrevista

Prof. Vicente Amato Neto; Dr. Jacyr Pasternak

Universidade de São Paulo

Texto completo disponível apenas em PDF.

Full text available only in PDF format.

  • 1. Blumberg N, Heal JM, Murphy P, Agarwal MM, Chuang C. Association between transfusions of whole blood and recurrense of cancer. British Medical Journal 293:530-533, 1986.
  • 2. Gascon P, Zoumbs NC, Young Ns. Immunologic abnormalities in patients receiving multiple blood transfusions. Annals of Internal Medicine 100:173-177, 1984.
  • 3. Hamblin T. Blood transfusions and cancer: anomalies explained? British Medical Journal 293:517-518, 1986.
  • 4. Kaplan BJ, Samaik S, Gitlin J, Lusher J. Diminished helper/supressor lymphocyte rations and natural killer activity in recipients of repeated blood transfusion. Blood The Journal of the American Society of Hematology 64:308-310, 1984.
  • 5. Selby JV, Friedman GD. Epidemiologic evidence of an association between body iron stores and risk of cancer. International Journal of Cancer 41:677-682, 1988.
  • 6. Stevens R, Jones Y, Micozzi M, Taylor PR. Body iron stores and the risk of cancer. The New England Journal of Medicine 319:1047-1052, 1988.
  • 7. Stevens RG, Beasley RP, Blumberg BS. Iron binding proteins and risk of cancer in Taiwan. Journal of the National Cancer Institute 76:605-610, 1986.

Datas de Publicação

  • Publicação nesta coleção
    27 Maio 2013
  • Data do Fascículo
    Mar 1990
Sociedade Brasileira de Medicina Tropical - SBMT Caixa Postal 118, 38001-970 Uberaba MG Brazil, Tel.: +55 34 3318-5255 / +55 34 3318-5636/ +55 34 3318-5287, http://rsbmt.org.br/ - Uberaba - MG - Brazil
E-mail: rsbmt@uftm.edu.br